<?xml version="1.0" encoding="UTF-8"?>
<ref id="B197-pharmaceutics-12-00171">
 <label>197.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Odiba</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ottah</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Ottah</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Anunobi</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Ukegbu</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Edeke</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Uroko</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Omeje</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Therapeutic nanomedicine surmounts the limitations of pharmacotherapy</article-title>
  <source>Open Med.</source>
  <year>2017</year>
  <volume>12</volume>
  <pub-id pub-id-type="doi">10.1515/med-2017-0041</pub-id>
 </element-citation>
</ref>
